Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
| Image |  |
|---|---|
| Description | scientific article published on 08 March 2016 |
| Author/s |
author: Michael A. Carducci Michael A.S. Jewett David Cella Toni K Choueiri George Wilding Janice P Dutcher Keith Flaherty |
| Publication date | March 8, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |